Bayer said it had agreed to delay a proposed settlement to deal with future claims relating to allegations that its widely used weedkiller Roundup caused cancer after a U.S. judge questioned the plan.
The German company said on Tuesday that lawyers representing those preparing a class action had withdrawn a request for court approval of the $1.25 billion scheme, part of a broader $10.9 billion agreement to settle close to 100,000 U.S. lawsuits related to Roundup.
“The withdrawal will enable the parties to more comprehensively address the questions recently raised by Federal District Court Judge Vince Chhabria of the Northern District of California who presides over the federal Roundup litigation,” Bayer said in a statement.
Last month Bayer agreed to pay as much as $10.9 billion to settle close to 100,000 U.S. lawsuits related to Roundup.
(Reporting by Keith Weir Editing by Arno Schuetze)
Was this article valuable?
Here are more articles you may enjoy.
AM Best: Social Inflation Drives Surge in Commercial Auto Liability Claims 
How Federal Ban on Intoxicating Hemp Products Will Reshape Risk, Coverage 
World’s Largest Retirement Community Set to Borrow $180 Million for More Homes 
Chubb CEO Greenberg: Industry Has to ‘Put Arms Around’ AI Liability 
